Evofem Biosciences Inc. [NASDAQ: EVFM] surged by $0.05 during the normal trading session on Monday and reaching a high of $3.03 during the day while it closed the day at $2.95. Evofem Biosciences Inc. stock has also loss -14.49% of its value over the past 7 days. However, EVFM stock has declined by -15.95% in the 3 months of the year. Over the past six months meanwhile, it has lost -52.50% and lost -52.19% year-on date.
The market cap for EVFM stock reached $229.69 million, with 78.70 million shares outstanding and 48.92 million shares in the current float. Compared to the average trading volume of 2.00M shares, EVFM reached a trading volume of 4544436 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Here’s what leading stock market gurus have to say about Evofem Biosciences Inc. [EVFM]:
Piper Sandler have made an estimate for Evofem Biosciences Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on June 08, 2020. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on October 16, 2019, representing the official price target for Evofem Biosciences Inc. stock.
The Average True Range (ATR) for Evofem Biosciences Inc. is set at 0.43 The Price to Book ratio for the last quarter was 147.50, with the Price to Cash per share for the same quarter was set at 0.13.
EVFM stock trade performance evaluation
Evofem Biosciences Inc. [EVFM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.49. With this latest performance, EVFM shares dropped by -40.40% in over the last four-week period, additionally sinking by -52.50% over the last 6 months – not to mention a drop of -53.54% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EVFM stock in for the last two-week period is set at 27.71, with the RSI for the last a single of trading hit 23.30, and the three-weeks RSI is set at 32.06 for Evofem Biosciences Inc. [EVFM]. The present Moving Average for the last 50 days of trading for this stock 4.82, while it was recorded at 3.05 for the last single week of trading, and 5.29 for the last 200 days.
Evofem Biosciences Inc. [EVFM]: An insightful look at the core fundamentals
When it comes to the capital structure of this company, Evofem Biosciences Inc. [EVFM] has a Total Debt to Total Equity ratio set at 1.26. Additionally, EVFM Total Debt to Total Capital is recorded at 1.24, with Total Debt to Total Assets ending up at 0.70.
Reflecting on the efficiency of the workforce at the company, Evofem Biosciences Inc. [EVFM] managed to generate an average of -$1,510,057 per employee.Evofem Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.90 and a Current Ratio set at 0.90.
Earnings per share (EPS) analysis for Evofem Biosciences Inc. [EVFM] stock
With the latest financial reports released by the company, Evofem Biosciences Inc. posted -0.97/share EPS, while the average EPS was predicted by analysts to be reported at -0.37/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -162.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EVFM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evofem Biosciences Inc. go to 73.50%.
Evofem Biosciences Inc. [EVFM]: Insider Ownership positions
There are presently around $175 million, or 47.80% of EVFM stock, in the hands of institutional investors. The top three institutional holders of EVFM stocks are: WOODFORD INVESTMENT MANAGEMENT LTD with ownership of 12,496,222, which is approximately -9.011% of the company’s market cap and around 2.00% of the total institutional ownership; INVESCO LTD., holding 11,886,993 shares of the stock with an approximate value of $34.47 million in EVFM stocks shares; and LINK FUND SOLUTIONS LTD, currently with $26.5 million in EVFM stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Evofem Biosciences Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 56 institutional holders increased their position in Evofem Biosciences Inc. [NASDAQ:EVFM] by around 8,529,051 shares. Additionally, 92 investors decreased positions by around 3,434,066 shares, while 32 investors held positions by with 48,432,740 shares. The mentioned changes placed institutional holdings at 60,395,857 shares, according to the latest SEC report filing. EVFM stock had 19 new institutional investments in for a total of 896,600 shares, while 30 institutional investors sold positions of 490,997 shares during the same period.